Skip to content

DENTSPLY SIRONA XRAY Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-$100K
IAR
Integra LifeSciencesIART
-$90K+81.8%
Globus Medical logo
Globus MedicalGMED
-$2.45M+6.3%
Novanta logo
NovantaNOVT
$248K-94.3%
Nordson logo
NordsonNDSN
$303K+494%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$196K+87.5%

Other financials

Income statement

See full
Revenue$880.0M+0.1%
Gross profit$427.0M-8.4%
Operating income-$35.0M-156%
Net income-$10.0M-150%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$190.0M-52.3%
Total debt$2.3B-3.8%
Total equity$1.3B-34.4%
Total assets$5.2B-13.6%

Cash flow

See full
Operating cash flow$40.0M+471%
CapEx$52.0M+174%
Free cash flow-$12.0M0.0%

Valuation

See full
Market cap$2.11B-22.1%

Profitability

See full
Gross margin48.9%-2.6pp
Operating margin-14.1%-3.9pp
Net margin-17.1%-3.9pp
FCF margin2.8%-4.6pp

Returns & leverage

See full
Return on equity-37.7%+4.0pp
Debt / equity1.8×+0.6×
Current ratio1.5×+0.4×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DENTSPLY SIRONA's gain/loss on asset sales?
DENTSPLY SIRONA (XRAY) reported gain/loss on asset sales of $6M in Q1 2026.
What is the long-term trend for DENTSPLY SIRONA's gain/loss on asset sales?
Over 2 years (2022 to 2024), DENTSPLY SIRONA's gain/loss on asset sales has grown at a 151.7% compound annual growth rate (CAGR), from -$3M to -$19M.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.